|
UK’s CAC Postmarket Vigilance Rules Are Now in Line With the EU’s MDD
Manufacturers of cardiac ablation catheters (CAC) marketed in the UK must have procedures in place to detect and report product malfunctions and deterioration, inadequate instructions for use and adverse events, according to a new guidance.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives